T2 Biosystems Inc (TTOO)
0.79
-0.01
(-1.25%)
USD |
NASDAQ |
Nov 05, 16:00
0.79
0.00 (0.00%)
After-Hours: 16:24
T2 Biosystems Gross Profit Margin (Quarterly): -37.96% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -37.96% |
| March 31, 2024 | -103.9% |
| December 31, 2023 | -53.31% |
| September 30, 2023 | -166.6% |
| June 30, 2023 | -147.9% |
| March 31, 2023 | -92.25% |
| December 31, 2022 | 33.63% |
| September 30, 2022 | -65.49% |
| June 30, 2022 | 14.04% |
| March 31, 2022 | 14.22% |
| December 31, 2021 | 23.18% |
| September 30, 2021 | 36.46% |
| June 30, 2021 | 27.83% |
| March 31, 2021 | 16.76% |
| December 31, 2020 | 4.01% |
| September 30, 2020 | -30.28% |
| June 30, 2020 | 9.87% |
| March 31, 2020 | -83.54% |
| December 31, 2019 | -17.63% |
| Date | Value |
|---|---|
| September 30, 2019 | -135.2% |
| June 30, 2019 | -167.2% |
| March 31, 2019 | -145.8% |
| December 31, 2018 | -214.2% |
| September 30, 2018 | -23.36% |
| June 30, 2018 | 12.03% |
| March 31, 2018 | -41.63% |
| December 31, 2017 | -279.7% |
| September 30, 2017 | -90.07% |
| June 30, 2017 | -108.1% |
| March 31, 2017 | -72.90% |
| December 31, 2016 | -138.8% |
| September 30, 2016 | -74.72% |
| June 30, 2016 | -79.90% |
| March 31, 2016 | 6.39% |
| December 31, 2015 | 10.19% |
| September 30, 2015 | 20.97% |
| June 30, 2015 | |
| March 31, 2015 | 98.40% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-166.6%
Minimum
Sep 2023
36.46%
Maximum
Sep 2021
-32.57%
Average
-17.63%
Median
Dec 2019
Gross Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp | 68.83% |
| Hologic Inc | 55.40% |
| Ekso Bionics Holdings Inc | 53.50% |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 76.19% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -149.2% |
| Return on Invested Capital | -410.0% |
| Profit Margin (Quarterly) | -459.2% |
| Operating Margin (Quarterly) | -490.5% |
| Return on Net Operating Assets | -307.8% |